Skip to main content

Table 1 Candidate prognostic factors for participants included in the study (n = 3657)

From: Prognostic factors of total hip replacement during a 2-year period in participants enrolled in supervised education and exercise therapy: a prognostic study of 3657 participants with hip osteoarthritis

Variables

Coding for analysis

Age, mean (SD)

66.5 (8.6)

Continuous

Sex, female, n (%)

2687 (73%)

Categorical

BMI, kg/m2, mean (SD)

26.9 (4.7)

Continuous

Current smoking, n (%)

353 (9.7%)

Categorical

Living alone, n (%)

1006 (28%)

Categorical

Sick leave due to hip problems for more than one month during the past 12 months, n (%)

93 (2.5%)

Categorical

Educational level, n (%)

 Primary and lower secondary school (9–10 years)

 Higher general examination program (12-13 years)

 Short-cycle higher education (less than three years more)

 Medium-cycle higher education (three to four years more)

 Long-cycle higher education (minimum five years more)

620 (17%)

372 (10%)

665 (18%)

1550 (42%)

450 (12%)

Categorical

Employment, n (%)

 Employed/student

 Unemployed

 Retired

 Self-imposed early retirement

 Early retirement due to low ability to work

 On sick leave full time or part time

1026 (28%)

49 (1.3%)

2131 (58%)

222 (6.1%)

119 (3.3%)

110 (3.0%)

Categorical

Collapsed as either “no” regardless of what kind of retirement or “yes” regardless of current sick leave or temporary unemployment.

Self-reported radiographic OA, n (%)

 Had x-ray with radiographic OA

 Had x-ray without radiographic OA

 Had no x-ray or do not know

3007 (82%)

131 (3.6%)

519 (14%)

Categorical

Collapsed as either “present” (had x-ray with radiographic OA) or “absent” (had x-ray with no radiographic OA, had no x-ray or do not know).

Wait-listed for THR of the index hip, n (%)

100 (2.7%)

Categorical

Joint replacement in the other hip or knees, n (%)

362 (9.9%)

Categorical

Comorbidities, n (%)

 None

 One

 Two

 Three or more

1425 (39%)

1321 (36%)

616 (17%)

295 (8%)

Categorical

Pain medication the last 3 months, n (%)

 No use of pain medication

 Has used only paracetamol/acetaminophen and/or NSAID

 Has used opioids (everyone using opioids also used paracetamol/acetaminophen and/or NSAID)

1308 (36%)

2033 (56%)

316 (8.6%)

Categorical:

Collapsed into pain medication usage in the past 3 months “yes” (used paracetamol, acetaminophen, NSAID or opioids) or “no” (did not use any type of pain medication)

Fear of joint damage from physical activity, n (%)

365 (10%)

Categorical

Bilateral hip symptoms, n (%)

946 (26%)

Categorical

Number of painful areas during the last 24 h (0–56 areas market on a body chart front and rear view), median (IQR)

3 (3)

Continuous

Hip pain (average) during the last month (VAS 0–100), median (IQR)

48 (21)

Continuous

Duration of symptoms in the index joint, months (n = 2770), median (IQR)

24 (40)

Not included as a prognostic factor

UCLA activity score (1–10), median (IQR)

6 (3)

Categorical:

In the analysis, the original 10 categories were collapsed into 5

HOOS quality of life subscale score, median (IQR) (0–100)

50 (19)

Continuous

Self-Efficacy (ASES) median (IQR) (10–100)

68 (26)

Continuous

Health-related quality of life (EQ-5D-5L), median (IQR) (− 0.624 to 1)

0.723 (0.110)

Continuous

40 m walk test (m/s), median (IQR)

1.49 (0.43)

Continuous

30 s chair stand test (no. of rises), median (IQR)

12 (5)

Continuous

  1. UCLA, University of California, Los Angeles Physical Activity Scale (1–10). Level 10 is very high and 1 is very low. HOOS QoL, Hip disability and Osteoarthritis Outcome Score, the quality-of-life subscale score (0–100 worst to best).
  2. ASES, Arthritis Self-Efficacy Scale. Only subscales for pain and other symptoms were collected and a mean were calculated. Higher scores indicate higher self-efficacy. EQ-5D-5L, The EuroQoL 5-Dimensions 5-Level questionnaire presented as an index value scored using the Danish crosswalk value set